O JPMorgan rebaixa a Colgate-Palmolive e a Clorox, mas ambas as empresas superam as estimativas de ganhos. JPMorgan downgrades Colgate-Palmolive and Clorox, but both companies beat earnings estimates.

A JPMorgan Chase & Co. reduziu sua meta de preço para Colgate-Palmolive para US $ 95,00, mas manteve uma classificação de "peso excessivo". JPMorgan Chase & Co. lowered its price target for Colgate-Palmolive to $95.00 but kept an "overweight" rating. A Colgate-Palmolive superou as expectativas de ganhos com US$0,91 EPS. Colgate-Palmolive surpassed earnings expectations with $0.91 EPS. Para Clorox, o JPMorgan reduziu sua meta para US $ 151,00, mantendo uma classificação "neutra". For Clorox, JPMorgan lowered its target to $151.00, maintaining a "neutral" rating. Clorox informou US $ 1,55 EPS, superando as estimativas em US $ 0,16. Clorox reported $1.55 EPS, beating estimates by $0.16. Os investidores institucionais têm vindo a ajustar as suas participações em ambas as empresas, refletindo o sentimento de mercado misto. Institutional investors have been adjusting their holdings in both companies, reflecting mixed market sentiment.